TCIM
KBIO

TIAA CREF Investment Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

TIAA CREF Investment Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,911
Closed -$63K – 3298
2014
Q1 		$63K Hold
2,911
– – ﹤0.01% 3116
2013
Q4 		$103K Hold
2,911
– – ﹤0.01% 3107
2013
Q3 		$105K Hold
2,911
– – ﹤0.01% 3077
2013
Q2 		$132K Buy
+2,911
New +$132K ﹤0.01% 3054

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

TIAA CREF Investment Management's KBIO Position: Q2 2014 in Review

TIAA CREF Investment Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q2 2014, closing a stake of 2,911 shares — an estimated $63K sold.

TIAA CREF Investment Management first reported a position in KBIO in Q2 2013 and held it in 4 quarters. The position peaked at $132K in Q2 2013. 43 funds tracked by Wall St. Rank hold KBIO as of Q2 2014.

  • TIAA CREF Investment Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q2 2014 after selling out during the quarter.
  • TIAA CREF Investment Management sold 2,911 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q2 2014, an estimated $63K.
  • TIAA CREF Investment Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 4 quarters.
  • TIAA CREF Investment Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $132K in Q2 2013.
  • 43 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q2 2014.

Based on TIAA CREF Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.